National Association of Chain Drug Stores
FDANonrulemakingFDA-2019-D-1615

Instructions for Use -- Patient Labeling for Human Prescription Drug and Biological Products and Drug-Device and Biologic-Device Combination Products -- Content and Format; Draft Guidance for Industry; Availability

RIN
Last modified
Jul 15, 2022
Comment window
closed 2520d ago
National Association of Chain Drug Stores filings
1

Activity

National Association of Chain Drug Stores filed 1 comment on this docket between Sep 10, 2019 and Sep 10, 2019. 0 other organizations filed here. The comment window closed 2520d ago.

What National Association of Chain Drug Stores filed (1)

Sep 10, 2019· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2019-D-1615-0007

Please see the attached comments of the National Association of Chain Drug Stores on the draft guidance outlining the content and format of an Instructions for Use (IFU) document for patients who use drug products that have complicated or detailed patient-use instructions. We thank the Food and Drug Administration for considering our input on this matter.

Abstract

No abstract recorded.

View on regulations.gov →